日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

VALOR-CKD: A Multicenter, Randomized, Double-Blind Placebo-Controlled Trial Evaluating Veverimer in Slowing Progression of CKD in Patients with Metabolic Acidosis

VALOR-CKD:一项多中心、随机、双盲、安慰剂对照试验,评估维维瑞默在延缓代谢性酸中毒患者慢性肾脏病进展中的疗效。

Tangri, Navdeep; Mathur, Vandana S; Bushinsky, David A; Klaerner, Gerrit; Li, Elizabeth; Parsell, Dawn; Stasiv, Yuri; Walker, Michael; Wesson, Donald E; Wheeler, David C; Perkovic, Vlado; Inker, Lesley A

Randomized, Controlled Trial of TRC101 to Increase Serum Bicarbonate in Patients with CKD

一项随机对照试验研究了TRC101提高慢性肾脏病患者血清碳酸氢盐水平的疗效。

Bushinsky, David A; Hostetter, Thomas; Klaerner, Gerrit; Stasiv, Yuri; Lockey, Claire; McNulty, Sarah; Lee, Angela; Parsell, Dawn; Mathur, Vandana; Li, Elizabeth; Buysse, Jerry; Alpern, Robert